| 86R6468 BEE-F  
---|---  
|  By: Zedler | H.B. No. 4285  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to the authority of pharmacists to furnish certain  
| medications.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Section 483.001(11), Health and Safety Code, is  
| amended to read as follows:  
|  (11) "Practice of pharmacy" _has the meaning assigned_  
| _by Section 551.003, Occupations Code_ [ ~~means:~~  
|  [ ~~(A)~~ ~~~~ ~~~~ ~~provision of those acts or services~~  
|  ~~necessary to provide pharmaceutical care;~~  
|  [ ~~(B)~~ ~~~~ ~~~~ ~~interpretation and evaluation of~~  
|  ~~prescription drug orders or medication orders;~~  
|  [ ~~(C)~~ ~~~~ ~~~~ ~~participation in drug and device selection~~  
|  ~~as authorized by law, drug administration, drug regimen review, or~~  
|  ~~drug or drug-related research;~~  
|  [ ~~(D) provision of patient counseling;~~  
|  [ ~~(E) responsibility for:~~  
|  [ ~~(i)~~ ~~~~ ~~~~ ~~dispensing of prescription drug orders~~  
|  ~~or distribution of medication orders in the patient's best~~  
|  ~~interest;~~  
|  [ ~~(ii)~~ ~~~~ ~~~~ ~~compounding and labeling of drugs and~~  
|  ~~devices, except labeling by a manufacturer, repackager, or~~  
|  ~~distributor of nonprescription drugs and commercially packaged~~  
|  ~~prescription drugs and devices;~~  
|  [ ~~(iii)~~ ~~~~ ~~~~ ~~proper and safe storage of drugs and~~  
|  ~~devices; or~~  
|  [ ~~(iv)~~ ~~~~ ~~~~ ~~maintenance of proper records for~~  
|  ~~drugs and devices. In this subdivision, "device" has the meaning~~  
|  ~~assigned by Subtitle J, Title 3, Occupations Code; or~~  
|  [ ~~(F)~~ ~~~~ ~~~~ ~~performance of a specific act of drug~~  
|  ~~therapy management for a patient delegated to a pharmacist by a~~  
|  ~~written protocol from a physician licensed by the state under~~  
|  ~~Subtitle B, Title 3, Occupations Code~~ ].  
|  SECTION 2. Subchapter C, Chapter 157, Occupations Code, is  
| amended by adding Section 157.102 to read as follows:  
|  _Sec._ ___157.102._ _____DELEGATION TO PHARMACIST TO FURNISH CERTAIN_  
| _DRUGS. (a) In this section:_  
|  _(1)_ _____"Acute condition" means a condition or disease_  
| _that begins abruptly, intensifies rapidly, and is generally not_  
| _long-lasting._  
|  _(2)_ _____"Pharmacist" has the meaning assigned by Section_  
| _551.003._  
|  _(3)_ _____"Tobacco cessation drug" means a prescription drug_  
| _approved by the United States Food and Drug Administration for use_  
| _in the treatment of nicotine or smoking addiction._  
|  _(4)_ _____"Travel drug" means a prescription drug_  
| _recommended by the federal Centers for Disease Control and_  
| _Prevention for individuals traveling outside of the United States_  
| _for the prevention and management of a disease before a diagnosis of_  
| _the disease._  
|  _(5)_ _____"Waived clinical laboratory test" means a clinical_  
| _laboratory test that is classified as waived under federal_  
| _regulations issued under the Clinical Laboratory Improvement_  
| _Amendments of 1988 (42 U.S.C. Section 263a)._  
|  _(6)_ _____"Written protocol" means a physician's written_  
| _order, standing medical order, standing delegation order, or other_  
| _order or protocol as defined by rule of the board._  
|  _(b)_ _____Notwithstanding any other law, a pharmacist may furnish_  
| _to a patient, as provided by a physician's written protocol, a_  
| _prescription drug that is:_  
|  _(1)_ _____a drug to treat an acute condition that is_  
| _identified through performance of one of the following tests, if_  
| _the test is a waived clinical laboratory test:_  
|  _(A)_ _____a rapid strep test or rapid antigen detection_  
| _test used in the identification of group A streptococcus (GAS); or_  
|  _(B)_ _____a rapid influenza diagnostic test used in the_  
| _identification of influenza types A and B;_  
|  _(2) a self-administered hormonal contraceptive;_  
|  _(3) a travel drug;_  
|  _(4) a prenatal vitamin supplement;_  
|  _(5) a tobacco cessation drug;_  
|  _(6) a vitamin D supplement; or_  
|  _(7)_ _____a drug identified by the executive commissioner of_  
| _the Health and Human Services Commission by rule as necessary for_  
| _pharmacists to furnish to patients for public health purposes._  
|  _(c)_ _____The board shall adopt rules jointly with the Texas State_  
| _Board of Pharmacy to establish the minimum content of the written_  
| _protocol required under Subsection (b). The written protocol may_  
| _permit a pharmacist to furnish a prescription drug to a patient_  
| _without an established physician-patient relationship._  
|  _(d)_ _____A written protocol under this section must require_  
| _notice to the patient's primary care physician, as identified by_  
| _the patient if the patient has a primary care physician, and_  
| _prescribe the period for providing the notice and the form of the_  
| _notice, in accordance with prevailing practices for the provision_  
| _of notice to a patient's primary care physician. The period for_  
| _providing the notice for furnishing a drug under Subsection (b)(1)_  
| _may not be later than the 14th day after the date the drug is_  
| _furnished by the pharmacist._  
|  SECTION 3. Section 551.003(33), Occupations Code, is  
| amended to read as follows:  
|  (33) "Practice of pharmacy" means:  
|  (A) providing an act or service necessary to  
| provide pharmaceutical care;  
|  (B) interpreting or evaluating a prescription  
| drug order or medication order;  
|  (C) participating in drug or device selection as  
| authorized by law, and participating in drug administration, drug  
| regimen review, or drug or drug-related research;  
|  (D) providing patient counseling;  
|  (E) being responsible for:  
|  (i) dispensing a prescription drug order or  
| distributing a medication order;  
|  (ii) compounding or labeling a drug or  
| device, other than labeling by a manufacturer, repackager, or  
| distributor of a nonprescription drug or commercially packaged  
| prescription drug or device;  
|  (iii) properly and safely storing a drug or  
| device; or  
|  (iv) maintaining proper records for a drug  
| or device;  
|  (F) performing for a patient a specific act of  
| drug therapy management delegated to a pharmacist by a written  
| protocol from a physician licensed in this state in compliance with  
| Subtitle B; [ ~~or~~ ]  
|  (G) administering an immunization or vaccination  
| under a physician's written protocol _; or_  
|  _(H)_ _____furnishing a prescription drug to a patient_  
| _under a physician's written protocol under Section 157.102_.  
|  SECTION 4. Subchapter B, Chapter 562, Occupations Code, is  
| amended by adding Section 562.058 to read as follows:  
|  _Sec._ ___562.058._ _____TRAINING REQUIRED TO INITIATE DRUG ORDER OR_  
| _FURNISH CERTAIN DRUGS. (a) A pharmacist may not furnish a_  
| _prescription drug under Section 157.102 unless the pharmacist has_  
| _completed a training program that is approved by the board and is_  
| _relevant to the condition treated by the drug._  
|  _(b)_ _____The board shall adopt rules jointly with the Texas_  
| _Medical Board to establish the minimum content of the training_  
| _program required under Subsection (a)._  
|  SECTION 5. Not later than January 1, 2020, the Texas State  
| Board of Pharmacy and the Texas Medical Board shall adopt the rules  
| required under Sections 157.102 and 562.058, Occupations Code, as  
| added by this Act.  
|  SECTION 6. (a) Except as provided by Subsection (b) of this  
| section, this Act takes effect January 1, 2020.  
|  (b) Section 5 of this Act takes effect September 1, 2019.

